Zota Health CareNSE:ZOTA +0.44%76 Quick Ratio is 1.11 as of Mar. 2026, which is 9% below its 10-year median of 1.22. GuruFocus rates NSE:ZOTA with a GF Score™ of 76/100 and a GF Value™ of ₹1,588.32 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,411 Biotechnology companies, Zota Health Care ranks worse than 78.88% on this metric.
Zota Health Care has a quick ratio of 1.11. It generally indicates good short-term financial strength.
The historical rank and industry rank for Zota Health Care's Quick Ratio or its related term are showing as below:
NSE:ZOTA'
s Quick Ratio Range Over the Past 10 Years
Min: 0.78 Med: 1.22 Max: 1.81
Current: 1.11
During the past 13 years, Zota Health Care's highest Quick Ratio was 1.81. The lowest was 0.78. And the median was 1.22.
NSE:ZOTA's Quick Ratio is ranked worse than 78.88% of 1411
companies
in the Biotechnology industry
Industry Median: 3.6
vs NSE:ZOTA: 1.11
Zota Health Care (NSE:ZOTA) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Zota Health Care Quick Ratio Related Terms
Zota Health Care Quick Ratio Historical Data
* Premium members only.
The historical data trend for Zota Health Care's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ZOTA vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, Zota Health Care's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zota Health Care Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zota Health Care's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Zota Health Care's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Zota Health Care's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zota Health Care (NSE:ZOTA) has a Quick Ratio of 1.11 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Zota Health Care and its competitors. This is near median its historical median of 1.22. Over the past decade, Zota Health Care's Quick Ratio has ranged from 0.78 to 1.81. According to the industry distribution chart, Zota Health Care ranks #1113 out of 1411 companies in the Biotechnology industry, placing it in the top 78.9%.
Is Zota Health Care's Quick Ratio too high?
Zota Health Care's current Quick Ratio of 1.11 is near median its 10-year median of 1.22. Over the past 10 years, this metric has ranged from a low of 0.78 to a high of 1.81. The Biotechnology industry median Quick Ratio is 3.60. Zota Health Care's value of 1.11 is 69.2% below this industry median. Based on the distribution chart, Zota Health Care ranks #1113 out of 1411 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zota Health Care has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zota Health Care's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Zota Health Care ranks #1113 out of 1411 companies for Quick Ratio. This places Zota Health Care in the lower half of its industry. The industry median Quick Ratio is 3.60. Zota Health Care's value of 1.11 is 69.2% below this benchmark. Historically, Zota Health Care's own Quick Ratio has ranged from 0.78 to 1.81 over the past decade. While the company's 10-year median is 1.22 vs. the industry median of 3.60, Zota Health Care has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,411 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zota Health Care's current Quick Ratio of 1.11 is 69.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Zota Health Care and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zota Health Care's current Quick Ratio is 1.11, which is near median its own 10-year median of 1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zota Health Care stock overvalued right now?
Based on GuruFocus' analysis, Zota Health Care (NSE:ZOTA) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,588.32, compared to a current price of ₹1,444.90 — trading 9% below its estimated fair value. The current Quick Ratio is 1.11, which is near median its 10-year median of 1.22 and 69.2% below the Biotechnology industry median of 3.60. Zota Health Care's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Zota Health Care (NSE:ZOTA), the current Quick Ratio is 1.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zota Health Care (NSE:ZOTA) Overvalued in 2026?
Based on GuruFocus' analysis, Zota Health Care stock appears to be undervalued.
The current stock price of ₹1,444.90 is trading 9% below its estimated GF Value™ of ₹1,588.32.
GuruFocus considers Zota Health Care to be Fairly Valued.
Key valuation signals for NSE:ZOTA:
Quick Ratio: 1.11 (near median its 10-year median of 1.22)
GF Value™: ₹1,588.32 vs. price of ₹1,444.90 (9% below fair value)
Industry Position: 69.2% below the Biotechnology median (#1113 of 1411)
No single metric tells the full story. See the NSE:ZOTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zota Health Care Ltd is engaged in the manufacturing, trading, and export of pharmaceutical products. The company caters to both domestic and international markets. It offers a vast range of pharmaceutical, nutraceutical, ayurvedic, and OTC products in India and overseas as well.
76GF Score
Get the complete analysis for NSE:ZOTA
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ZOTA has been successfully added to your 
